Prognostic and predictive impact of circulating tumor DNA in patients with advanced cancers treated with immune checkpoint blockade

QU Zhang, J Luo, S Wu, H Si, C Gao, W Xu… - Cancer discovery, 2020 - AACR
The utility of circulating tumor DNA (ctDNA) as a biomarker in patients with advanced
cancers receiving immunotherapy is uncertain. We therefore analyzed pretreatment (n= 978) …
被引用次数：246 相关文章

Prognostic and Predictive Impact of Circulating Tumor DNA in Patients with Advanced Cancers Treated with Immune Checkpoint Blockade.

Q Zhang, J Luo, S Wu, H Si, C Gao, W Xu… - Cancer …, 2020 - europepmc.org
The utility of circulating tumor DNA (ctDNA) as a biomarker in patients with advanced
cancers receiving immunotherapy is uncertain. We therefore analyzed pretreatment (n= 978) …

Prognostic and Predictive Impact of Circulating Tumor DNA in Patients with Advanced Cancers Treated with Immune Checkpoint Blockade

Q Zhang, J Luo, S Wu, H Si, C Gao, W Xu… - Cancer …, 2020 - pubmed.ncbi.nlm.nih.gov
The utility of circulating tumor DNA (ctDNA) as a biomarker in patients with advanced
cancers receiving immunotherapy is uncertain. We therefore analyzed pretreatment (n= 978) …
[HTML] nih.gov

[HTML][HTML] Prognostic and Predictive Impact of Circulating Tumor DNA in Patients with Advanced Cancers Treated with Immune Checkpoint Blockade

Q Zhang, J Luo, S Wu, H Si, C Gao, W Xu… - Cancer …, 2020 - ncbi.nlm.nih.gov
The utility of circulating tumor DNA (ctDNA) as a biomarker in patients with advanced
cancers receiving immunotherapy is uncertain. We therefore analyzed pretreatment (n= 978) …

Prognostic and Predictive Impact of Circulating Tumor DNA in Patients with Advanced Cancers Treated with Immune Checkpoint Blockade

Q Zhang, J Luo, S Wu, H Si, C Gao, W Xu… - Cancer …, 2020 - cir.nii.ac.jp
抄録< jats: title> Abstract</jats: title>< jats: sec>< jats: title/>< jats: p> The utility of circulating
tumor DNA (ctDNA) as a biomarker in patients with advanced cancers receiving …